HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE COVER ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Submit a letter to the editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Morrow, C. P. Search for Related Content PubMed PubMed Citation Articles by Morrow, C. P.

CA: A Cancer Journal for Clinicians, Vol 34, 220-231, Copyright © 1984 by American Cancer Society

The Benefits of Estrogen To the Menopausal Woman Outweigh the Risks of Developing Endometrial Cancer

¹ Professor of Obstetrics and Gynecology and Director of the Division of Gynecologic Oncology of the University of Southern California School of Medicine in Los Angeles, California.

According to animal, human, and laboratory data, the major, life-threatening risks to the woman from exogenous estrogens are neoplastic and cardiovascular. These risks are, to some extent, related to dose, duration of therapy, and certain predisposing individual factors. Except for endometrial carcinoma, the risks have not been adequately studied and are therefore not defined. Because of their potential magnitude collectively, no intelligent assessment of the risk-benefit ratios can be carried out until the effect, if any, on the susceptibility for breast carcinoma, ovarian carcinoma, and cardiovascular disease is determined.